Letter Re: Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
database[Title] 2025-12-11
Eur J Cancer. 2025 Dec 1;232:116150. doi: 10.1016/j.ejca.2025.116150. Online ahead of print.
NO ABSTRACT
PMID:41349153 | DOI:10.1016/j.ejca.2025.116150